Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Aspiration system for stroke thrombectomy recalled, discontinued after FDA raises concerns
The devices are being recalled and discontinued after the FDA shared a series of concerns. This is a Class I recall, meaning using this system could result in serious injuries or death.
Perfuze celebrates a ‘major milestone’ for new-look stroke catheter
The Millipede 088 was designed to treat large vessel occlusion stroke patients by “ingesting” the blood clot as opposed to dragging it through the patient’s blood vessels.
FDA warns that certain coronary imaging catheters are being removed from market over safety concerns
A catheter sheath detached during use and was left in the patient’s body. It was successfully removed, but the FDA said it is now evaluating the potential risk to others going forward. There is no official recall at this time.
Mediterranean diets that include some lean red meat can still boost cardiovascular health
The study's authors focused on blood pressure reductions and arterial stiffness, sharing their findings in Current Developments in Nutrition.
Late-breaking cardiovascular drug trials took center stage at ACC.25
Richard Kovacs, MD, detailed some the most important late-breaking cardiology pharmacology trials presented at ACC.25.

Blood transfusions limit brain damage, lead to ‘profoundly improved’ stroke outcomes

Blood substitution therapy removes inflammatory cells from the body, limiting some of the more extreme side effects associated with experiencing a stroke.

American Heart Association, Bill Gates donate $3.3M to new research initiative

The project includes a new technology research center at Boston University and support for scientists around the world.

Evolocumab use benefits people living with HIV, dyslipidemia patients

Overall, the PCSK9 inhibitor was associated with a steady increase in coronary artery area and “significant coronary blood flow improvement.”

Signs of COVID-19 still in blood sample 40 days after symptom resolution

“This case should be taken into consideration as blood donation policies are being crafted," the researchers wrote.

THALES trial results: Can ticagrelor and aspirin reduce stroke rates for at-risk patients?

Results of the trial, which included more than 11,000 patients, were published in the New England Journal of Medicine.

'A missed opportunity': Statin use low among patients with peripheral artery disease

Researchers tracked statin use among patients with peripheral artery disease, cerebrovascular disease and coronary heart disease.

When COVID-19 patients have an acute ischemic stroke (AIS), it can have an especially devastating effect.

Comparing COVID-19's stroke rate with those of other respiratory infections

The researchers compared hospitalized COVID-19 patients with influenza patients treated in 2018.

Vascular & Endovascular

Aspiration system for stroke thrombectomy recalled, discontinued after FDA raises concerns

Perfuze celebrates a ‘major milestone’ for new-look stroke catheter

FDA warns that certain coronary imaging catheters are being removed from market over safety concerns

Mediterranean diets that include some lean red meat can still boost cardiovascular health

Late-breaking cardiovascular drug trials took center stage at ACC.25